A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers-Reference-Cited by-同舟云学术

A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers

Published:2020-01-29 Issue:9 Volume:26 Page:2188-2202
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Mathur Divya^ORCID,Root Adam R.^ORCID,Bugaj-Gaweda Bozena,Bisulco Stephanie,Tan Xingzhi,Fang Wei,Kearney Jessica C.,Lucas Justin,Guffroy Magali,Golas Jonathan,Rohde Cynthia M.,Stevens Chad,Kamperschroer Cris,Kelleher Kerry,Lawrence-Henderson Rosemary F.,Upeslacis Erik,Yao Johnny,Narula Jatin,LaVallie Edward R.,Fernandez Diane R.,Buetow Bernard S.,Rosfjord Edward^ORCID,Bloom Laird,King Lindsay E.,Tchistiakova Lioudmila,Nguyen Anhco,Sapra Puja

Funder

Pfizer Worldwide Research and Development

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a novel T cell-engaging bispecific antibody for elimination of L1CAM-positive tumors;Biomedicine & Pharmacotherapy;2024-05

2. A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment;Blood Advances;2024-01-23

3. Immunotherapy of microsatellite stable colorectal cancer: resistance mechanisms and treatment strategies;Postgraduate Medical Journal;2024-01-11

4. Recent advancements in immunotherapy for colorectal cancer;Colorectal Cancer;2024

5. Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature;Frontiers in Oncology;2023-10-20